DAGCO Inc’s Plus Therapeutics PSTV Stock Holding History

DAGCO Inc’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,035	Closed	-$4.21K	–	286
2026 Q1	$4.21K	Hold	1,035	–	–	﹤0.01%	317
2025 Q4	$13.3K	Hold	1,035	–	–	﹤0.01%	269
2025 Q3	$17.7K	Buy	+1,035	New	+$12.7K	﹤0.01%	249

Other funds holding PSTV

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DAGCO Inc's PSTV Position: Q2 2026 in Review

DAGCO Inc sold out of Plus Therapeutics (PSTV) in Q2 2026, closing a stake of 1,035 shares — an estimated $4.21K sold.

DAGCO Inc first reported a position in PSTV in Q3 2025 and held it in 3 quarters. The position peaked at $17.7K in Q3 2025. 4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

DAGCO Inc reported no remaining Plus Therapeutics position as of Q2 2026 after selling out during the quarter.
DAGCO Inc sold 1,035 Plus Therapeutics shares in Q2 2026, an estimated $4.21K.
DAGCO Inc first reported a position in Plus Therapeutics in Q3 2025 and held it in 3 quarters.
DAGCO Inc's Plus Therapeutics position peaked at $17.7K in Q3 2025.
4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.